Rhone-Poulenc's Rhobio in joint gene maize project
Rhobio, a joint venture between French drugs group Rhone-Poulenc and research firm Biogemma, said it had signed a research deal with Celera AgGen to seek out new maize genes. The three-year
Rhobio, a joint venture between French drugs group Rhone-Poulenc and research firm Biogemma, said it had signed a research deal with Celera AgGen to seek out new maize genes. The three-year